[HTML][HTML] Oxidative stress, atherogenic dyslipidemia, and cardiovascular risk

J Vekic, K Stromsnes, S Mazzalai, A Zeljkovic, M Rizzo… - Biomedicines, 2023 - mdpi.com
Oxidative stress is the consequence of an overproduction of reactive oxygen species (ROS)
that exceeds the antioxidant defense mechanisms. Increased levels of ROS contribute to the …

[HTML][HTML] Ideal P2Y12 inhibitor in acute coronary syndrome: a review and current status

A Pradhan, A Tiwari, G Caminiti, C Salimei… - International Journal of …, 2022 - mdpi.com
Dual antiplatelet therapy (DAPT) has remained the cornerstone for management of acute
coronary syndrome (ACS) over the years. Clopidogrel has been the quintessential P2Y12 …

[HTML][HTML] Long non-coding RNAs as biomarkers and therapeutic targets for ischemic stroke

G Sufianova, A Shumadalova, Y Wenhao… - Non-coding RNA …, 2022 - Elsevier
Background The problem of ischemic stroke (IS) has become increasingly important in
recent years, as it ranks first in the structure of disability and mortality, crowding out other …

LOX-1 Receptor: A diagnostic tool and therapeutic target in atherogenesis

N Pyrpyris, K Dimitriadis, E Beneki, P Iliakis… - Current Problems in …, 2023 - Elsevier
Abstract Low Density Lipoprotein (LDL) and oxidized LDL (oxLDL) are major contributors to
atherogenesis, as endogenous antigens, via several receptors such as LOX 1. A PubMed …

[HTML][HTML] LOX-1 in Cardiovascular Disease: A Comprehensive Molecular and Clinical Review

ME Sánchez-León, KJ Loaeza-Reyes… - International Journal of …, 2024 - mdpi.com
LOX-1, ORL-1, or lectin-like oxidized low-density lipoprotein receptor 1 is a transmembrane
glycoprotein that binds and internalizes ox-LDL in foam cells. LOX-1 is the main receptor for …

[HTML][HTML] Whole blood coagulation in an ex vivo thrombus is sufficient to induce clot neutrophils to adopt a myeloid-derived suppressor cell signature and shed soluble …

J Leonard, D Kepplinger, V Espina, P Gillevet… - Journal of Thrombosis …, 2024 - Elsevier
Background Blood clots are living tissues that release inflammatory mediators including IL-
8/CXCL8 and MCP-1/CCL2. A deeper understanding of blood clots is needed to develop …

Relationship of Soluble Lectin‐Like Low‐Density Lipoprotein Receptor‐1 (sLOX‐1) With Inflammation and Coronary Plaque Progression in Psoriasis

EM Florida, H Li, CG Hong, EL Ongstad… - Journal of the …, 2023 - Am Heart Assoc
Background Psoriasis is a chronic inflammatory condition associated with coronary artery
disease risk. Uptake of oxidized low‐density lipoprotein by the lectin‐like low‐density …

[HTML][HTML] Lipid Profile and Small Dense Low-Density Lipoprotein in Acute Coronary Syndrome Patients: Relationships to Demographic, Clinical, Angiographic, and …

A Pradhan, R Kuka, P Vishwakarma, W Ali… - Journal of Clinical …, 2022 - mdpi.com
Background: Several lines of evidence have supported small dense low-density lipoproteins
(sd-LDL) as a marker of cardiovascular disease. The present study assessed the …

[HTML][HTML] Clinical Utility of Soluble Lectin Type Oxidized Low-Density Lipoprotein Receptor as a Biomarker for Myocardial Infarction and Stable Angina

R Narsini, V Bhaskar, H Luqman, SSR Parupati… - Cureus, 2023 - ncbi.nlm.nih.gov
Methods We enrolled 62 patients who underwent diagnostic coronary angiography (CAG)
and 30 healthy controls (21 men and nine women) and measured sLOX-1, troponin I, and …

Investigation of Lox-1 Primary Structure with 6 Anti-Lox-1 Antibodies Suggests that Human Platelets Do Not Express the 37 kDa Lox-1, 24 kDa Soluble Lox-1 or OLR1 …

J Leonard, CH Hu, R Veneziano… - Available at SSRN …, 2023 - papers.ssrn.com
Lectin-like oxidized low density lipoprotein-1 (Lox-1) is an endothelial scavenger receptor
for oxidized LDL. Several studies reported that Lox-1 is expressed by platelets and that in …